Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 1/2014

01-01-2014 | Original Article

The natural course and complications of alpha-mannosidosis—a retrospective and descriptive study

Authors: Dag Malm, Hilde Monica Frostad Riise Stensland, Øyvind Edvardsen, Øivind Nilssen

Published in: Journal of Inherited Metabolic Disease | Issue 1/2014

Login to get access

Abstract

Most alpha-mannosidosis patients described have been children and information on the natural course of the disorder has been based on a very limited number of observations. In order to assess the disease presentation in detail and to study disease characteristics, a study was started in 1991 and has been ongoing for over 20 years. Patients with confirmed alpha-mannosidosis were recruited through The International Society for Mannosidosis and Related Diseases (ISMRD) where families affected with alpha-mannosidosis received a questionnaire on general clinical information to be filled out by the responsible physician. The questionnaire was returned by 125 patients (64 %). Of these, 45 patients were 15 years old or older at the time of evaluation. The questionnaire allowed us to assess the following features: Facial dysmorphism, columnar disease, arthritis, myopathy, hearing impairment, mental impairment, psychosis, bone disease and motor function as well as general health. This study describes the progression of alpha-mannosidosis and may be helpful in determining the clinical characteristics for assessments of prognosis.
Appendix
Available only for authorised users
Literature
go back to reference Chester MA, Lundblad A, Öckerman PA et al (1982) Mannosidosis. In: Duran P, O’Brien JF (eds) Genetic errors of glyco-protein metabolism. Edi-Hermes, Milan, pp 89–120CrossRef Chester MA, Lundblad A, Öckerman PA et al (1982) Mannosidosis. In: Duran P, O’Brien JF (eds) Genetic errors of glyco-protein metabolism. Edi-Hermes, Milan, pp 89–120CrossRef
go back to reference Heikinheimo P, Helland R, Leiros HK et al (2003) The structure of bovine lysosomal alpha-mannosidase suggests a novel mechanism for low-pH activation. J Mol Biol 327(3):631–644PubMedCrossRef Heikinheimo P, Helland R, Leiros HK et al (2003) The structure of bovine lysosomal alpha-mannosidase suggests a novel mechanism for low-pH activation. J Mol Biol 327(3):631–644PubMedCrossRef
go back to reference Malm D, Halvorsen DS, Tranebjaerg L et al (2000) Immunodeficiency in alpha-mannosidosis: a matched case–control study on immunoglobulins, complement factors, receptor density, phagocytosis and intracellular killing in leucocytes. Eur J Pediatr 159(9):699–703PubMedCrossRef Malm D, Halvorsen DS, Tranebjaerg L et al (2000) Immunodeficiency in alpha-mannosidosis: a matched case–control study on immunoglobulins, complement factors, receptor density, phagocytosis and intracellular killing in leucocytes. Eur J Pediatr 159(9):699–703PubMedCrossRef
go back to reference Meikle PJ, Ranieri E, Simonsen H et al (2004) Newborn screening for lysosomal storage disorders: clinical evaluation of a two-tier strategy. Pediatrics 114(4):909–991PubMedCrossRef Meikle PJ, Ranieri E, Simonsen H et al (2004) Newborn screening for lysosomal storage disorders: clinical evaluation of a two-tier strategy. Pediatrics 114(4):909–991PubMedCrossRef
go back to reference Nilssen Ø, Berg T, Riise HM et al (1997) alpha-Mannosidosis: functional cloning of the lysosomal alpha-mannosidase cDNA and identification of a mutation in two affected siblings. Hum Mol Genet 6(5):717–726PubMedCrossRef Nilssen Ø, Berg T, Riise HM et al (1997) alpha-Mannosidosis: functional cloning of the lysosomal alpha-mannosidase cDNA and identification of a mutation in two affected siblings. Hum Mol Genet 6(5):717–726PubMedCrossRef
go back to reference Poupetová H, Ledvinová J, Berná L et al (2010) The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations. J Inherit Metab Dis 33:387–396PubMedCentralPubMedCrossRef Poupetová H, Ledvinová J, Berná L et al (2010) The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations. J Inherit Metab Dis 33:387–396PubMedCentralPubMedCrossRef
go back to reference Riise Stensland HMF, Klenow H, Hguyen LU et al (2012) Identification of 83 novel alpha-mannosidosis associated sequence variants: functional analysis of MAN2B1 missence mutations. Hum Mutat 33(3):511–520PubMedCrossRef Riise Stensland HMF, Klenow H, Hguyen LU et al (2012) Identification of 83 novel alpha-mannosidosis associated sequence variants: functional analysis of MAN2B1 missence mutations. Hum Mutat 33(3):511–520PubMedCrossRef
go back to reference Tollersrud OK, Berg T, Healy P et al (1997) Purification of bovine lysosomal alpha-mannosidase, characterization of its gene and determination of two mutations that cause alpha-mannosidosis. Eur J Biochem 246(2):410–419PubMedCrossRef Tollersrud OK, Berg T, Healy P et al (1997) Purification of bovine lysosomal alpha-mannosidase, characterization of its gene and determination of two mutations that cause alpha-mannosidosis. Eur J Biochem 246(2):410–419PubMedCrossRef
Metadata
Title
The natural course and complications of alpha-mannosidosis—a retrospective and descriptive study
Authors
Dag Malm
Hilde Monica Frostad Riise Stensland
Øyvind Edvardsen
Øivind Nilssen
Publication date
01-01-2014
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 1/2014
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-013-9622-2

Other articles of this Issue 1/2014

Journal of Inherited Metabolic Disease 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine